Earnings Estimate | Current Qtr. (Jun 2018) | Next Qtr. (Sep 2018) | Current Year (2019) | Next Year (2020) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 18 | 17 |
Avg. Estimate | 2.07 | 2.26 | 10.06 | 17.51 |
Low Estimate | 2.07 | 2.26 | 7.15 | 8.59 |
High Estimate | 2.07 | 2.26 | 15.1 | 25.1 |
Year Ago EPS | 1.37 | 1.16 | 6.27 | 10.06 |
Revenue Estimate | Current Qtr. (Jun 2018) | Next Qtr. (Sep 2018) | Current Year (2019) | Next Year (2020) |
---|---|---|---|---|
No. of Analysts | 0 | 0 | 17 | 16 |
Avg. Estimate | N/A | N/A | 51.96B | 66.43B |
Low Estimate | N/A | N/A | 45.84B | 51.98B |
High Estimate | N/A | N/A | 63.43B | 80.96B |
Year Ago Sales | N/A | N/A | 41.3B | 51.96B |
Sales Growth (year/est) | N/A | N/A | 25.80% | 27.80% |
Earnings History | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 |
---|---|---|---|---|
EPS Est. | 3.7 | 2.64 | 1.64 | 1.77 |
EPS Actual | 1.37 | 1.16 | 1.55 | 2.19 |
Difference | -2.33 | -1.48 | -0.09 | 0.42 |
Surprise % | -63.00% | -56.10% | -5.50% | 23.70% |
EPS Trend | Current Qtr. (Jun 2018) | Next Qtr. (Sep 2018) | Current Year (2019) | Next Year (2020) |
---|---|---|---|---|
Current Estimate | 2.07 | 2.26 | 10.06 | 17.51 |
7 Days Ago | 2.07 | 2.26 | 10.06 | 17.51 |
30 Days Ago | 2.07 | 2.26 | 10.1 | 17.42 |
60 Days Ago | 2.48 | 2.7 | 11.06 | 18.59 |
90 Days Ago | 2.48 | 2.7 | 10.95 | 18.29 |
EPS Revisions | Current Qtr. (Jun 2018) | Next Qtr. (Sep 2018) | Current Year (2019) | Next Year (2020) |
---|---|---|---|---|
Up Last 7 Days | N/A | N/A | N/A | N/A |
Up Last 30 Days | N/A | N/A | 4 | 1 |
Down Last 7 Days | N/A | N/A | N/A | N/A |
Down Last 30 Days | N/A | N/A | N/A | N/A |
Growth Estimates | BIOCON.BO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current Qtr. | 51.10% | N/A | N/A | N/A |
Next Qtr. | 94.80% | N/A | N/A | N/A |
Current Year | 60.40% | N/A | N/A | N/A |
Next Year | 74.10% | N/A | N/A | N/A |
Next 5 Years (per annum) | 17.10% | N/A | N/A | N/A |
Past 5 Years (per annum) | 6.31% | N/A | N/A | N/A |